Table 2 Features of peritoneal dissemination and residual disease among 59 advanced HGSOC patients in association with the pre-treatment serum CA125-Tn level
Parameter | n (%) | CA125-Tn Median (IQR) | CA125 Median (IQR) |
|---|---|---|---|
PIV | |||
 0 | 9 (15.3%) | 0.202 (0.157-0.262) | 507.5 (137.9-976.7) |
 2 | 10 (16.9%) | 0.268 (0.169-0.615) | 344.2 (181.4-1387.0) |
 4 | 8 (13.6%) | 0.313 (0.227-0.551) | 255.2 (179.5-367.1) |
 6 | 18 (30.5%) | 0.339 (0.207-0.691) | 706.8 (443.5-910.0) |
 8 | 11 (18.6%) | 0.915 (0.411-1.309) | 1659.0 (375.4-2944.0) |
 10 | 3 (5.1%) | 0.926 (0.461-1.248) | 2693.0 (573.6-5000.0) |
 P-value |  | 0.004 | 0.039 |
PIV category | |||
 PIV <8 | 45 (76.3%) | 0.315 (0.182-0.594) | 507.5 (197.3-910.0) |
 PIV ≥8 | 14 (23.7%) | 0.919 (0.461-1.248) | 2010.5 (466.8-2944.0) |
 P-value |  | 0.0001 | 0.005 |
Peritoneal dissemination pattern | |||
 Pelvic | 3 (5.1%) | 0.182 (0.096-0.536) | 507.5 (137.9-1151.0) |
 Lower abdominal | 16 (27.1%) | 0.235 (0.163-0.382) | 350.6 (175.1-1013.4) |
 Upper abdominal or miliary | 40 (67.8%) | 0.479 (0.316-0.916) | 634.5 (297.7-1655.5) |
 P-value |  | 0.011 | 0.234 |
Residual disease | |||
 0 | 17 (28.8%) | 0.220 (0.157-0.411) | 328.8 (168.8-976.7) |
 ≤1cm | 22 (37.3%) | 0.350 (0.207-0.606) | 627.3 (258.0-1652.0) |
 >1cm | 20 (33.9%) | 0.694 (0.355-1.001) | 634.5 (373.9-2176.0) |
 P-value |  | 0.005 | 0.129 |